Product Liability | Pharmaceutical Litigation | Health Law Depo‑Provera (medroxyprogesterone acetate), a long‑acting injectable progestin approved by the FDA in 1992, has recently come under scrutiny due to mounting evidence suggesting a potential link with intracranial meningioma tumors. This emerging body of medical data has catalyzed an explosion of litigation—including